Erceflora
A Drug Study Presented to the Faculty
of the Nursing Department
Mark Jade Adlawan, RN
In Partial Fulfillment of the
Requirements in NCM 207 – RLE
Pedia Nursing Rotation
By:
Arvin Joshua C. Lazarte, ST. N
BSN – 2L
January 31, 2021
Generic Name: bacillus clausii
Brand Name: Erceflora
Classification: Antidiarrheals
Mode of Action:
-
Contributes to the recovery of the intestinal microbial flora altered during the
course of microbial disorders of diverse origin. It produces various vitamins,
particularly group B vitamins thus contributing to correction of vitamin disorders
caused by antibiotics & chemotherapeutic agents. Promotes normalization of
intestinal flora.
Suggested dose (by manufacturer):
-
Adults 2-3 vials of 2 billion/5 mL suspChildren 2-11 years 1-2 vials of 2 billion/5
mL suspInfants >1 month 1-2 vials of 2 billion/5 mL susp.
Indication:
-
Acute diarrhea with duration of < 14 days due to infection, drugs, or poisons.
Chronic or persistent diarrhea with duration of > 14 days
Contraindication:
-
Not for use in immunocompromised patients (cancer patients on chemotherapy,
patients taking immunosuppressant meds)
.
Side Effects:
-
No known side effects
Adverse Effects:
-
No known side effects
Drug Interactions:
-
No known drug interactions
Nursing Responsibilities:
-
Follow the “five rights” in giving medicine right patient, right drug, right time, right
dose, and right route
Wash hand before and after applying the medicine.
Inform patient that this medication is to be used as directed by the physician..
Patients should be advised not to use this medication for any disorder other than
for which it was prescribed.
Patients should report any signs of local adverse reactions especially under
occlusive dressings
References:
https://hellodoctor.com.ph/drugs-supplements/erceflora/
https://watsonshealth.com.ph/erceflora/
https://www.scribd.com/home